Adherence to Repeat Fecal Occult Blood Testing in an Urban Community Health Center Network

[1]  Benjamin Quick,et al.  Self-Reported Barriers to Colorectal Cancer Screening in a Racially Diverse, Low-Income Study Population , 2013, Journal of Community Health.

[2]  N. Perrin,et al.  Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. , 2012, The American journal of managed care.

[3]  A. Rademaker,et al.  Literacy Barriers to Colorectal Cancer Screening in Community Clinics , 2012, Journal of health communication.

[4]  Marcie S Rubin,et al.  Fundamental causes of colorectal cancer mortality: the implications of informational diffusion. , 2012, The Milbank quarterly.

[5]  D. Fisher,et al.  Longitudinal Adherence to Fecal Occult Blood Testing Impacts Colorectal Cancer Screening Quality , 2011, The American Journal of Gastroenterology.

[6]  Joann G Elmore,et al.  Longitudinal Adherence With Fecal Occult Blood Test Screening in Community Practice , 2010, The Annals of Family Medicine.

[7]  D. Asch,et al.  Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. , 2010, American journal of public health.

[8]  Chyke A Doubeni,et al.  Primary Care, Economic Barriers to Health Care, and Use of Colorectal Cancer Screening Tests Among Medicare Enrollees Over Time , 2010, The Annals of Family Medicine.

[9]  R. Glasgow,et al.  Automated Telephone Calls Improved Completion of Fecal Occult Blood Testing , 2010, Medical care.

[10]  G. Murata,et al.  Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. , 2010, Preventive medicine.

[11]  T. Byers Two decades of declining cancer mortality: progress with disparity. , 2010, Annual review of public health.

[12]  L. Richardson,et al.  Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral Risk Factor Surveillance System, 2002 and 2004. , 2010, Ethnicity & disease.

[13]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[14]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[15]  E. Funkhouser,et al.  African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. , 2007, Cancer biomarkers : section A of Disease markers.

[16]  Terry Hyslop,et al.  A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening , 2007, Cancer.

[17]  P. Giorgi Rossi,et al.  The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial , 2005, Journal of medical screening.

[18]  R. Coates,et al.  Patterns and predictors of colorectal cancer test use in the adult U.S. population , 2004, Cancer.

[19]  G. Zou,et al.  A modified poisson regression approach to prospective studies with binary data. , 2004, American journal of epidemiology.

[20]  G. Ioannou,et al.  Predictors of colorectal cancer screening participation in the United States , 2003, American Journal of Gastroenterology.

[21]  B. Thompson,et al.  Rural Mexican American men's attitudes and beliefs about cancer screening. , 2000, Journal of cancer education : the official journal of the American Association for Cancer Education.

[22]  Russell S. Kirby,et al.  The Dartmouth Atlas of Health Care , 1998 .

[23]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[24]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.